
Alphatec Holdings, Inc.
ATECNasdaqCIK 1350653HealthcareFiscal year ends Dec 31
Reports and events: 345 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2916:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-437830 |
| 2026-08-0416:57 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-333051 |
| 2026-08-0416:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-332870 |
| 2026-06-1116:13 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-267552 |
| 2026-05-0516:56 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-206683 |
| 2026-05-0516:28 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-206530 |
| 2026-04-2916:26 ET | DEF 14A | Proxy statementPeriod 2026-06-10 | 0001193125-26-191867 |
| 2026-03-0316:14 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-088220 |
| 2026-02-2416:58 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-067393 |
| 2026-02-2416:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-067062 |
| 2026-01-1209:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-009910 |
| 2025-12-1718:25 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-25-323158 |
| 2025-11-0709:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-271197 |
| 2025-10-3016:57 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-258790 |
| 2025-10-3016:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-258609 |
| 2025-07-3116:51 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-100963 |
| 2025-07-3116:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-100924 |
| 2025-06-1316:03 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-086130 |
| 2025-05-0116:57 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-061974 |
| 2025-05-0116:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-061859 |
| 2025-04-2516:14 ET | DEF 14A | Proxy statementPeriod 2025-06-11 | 0000950170-25-058724 |
| 2025-04-2321:45 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-25-057646 |
| 2025-04-1120:34 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-25-053434 |
| 2025-04-0316:23 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-25-050434 |
| 2025-03-1416:03 ET | 8-K | 8.01 Other events | 0001193125-25-054786 |
| 2025-03-0717:27 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-25-049998 |
| 2025-03-0516:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-047166 |
| 2025-03-0316:02 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-044094 |
| 2025-02-2617:10 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-027916 |
| 2025-02-2616:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-027786 |
| 2025-02-0609:01 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-25-015038 |
| 2025-01-1309:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-004614 |
| 2024-11-1220:04 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-256228 |
| 2024-10-3016:54 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-119083 |
| 2024-10-3016:20 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000950170-24-119022 |
| 2024-07-3116:57 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-088670 |
| 2024-07-3116:20 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-088609 |
| 2024-06-1718:09 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-073859 |
| 2024-05-0716:59 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-054691 |
| 2024-05-0716:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-054549 |
| 2024-04-2616:44 ET | DEF 14A | Proxy statementPeriod 2024-06-12 | 0000950170-24-049245 |
| 2024-03-2219:57 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-075553 |
| 2024-03-1917:05 ET | 8-K | 7.01 Regulation FD disclosure | 0000950170-24-033642 |
| 2024-02-2716:52 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-021302 |
| 2024-02-2716:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-021203 |
| 2024-01-0809:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-002736 |
| 2024-01-0309:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-24-000544 |
| 2023-11-0616:51 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-059489 |
| 2023-11-0616:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-059413 |
| 2023-10-2717:31 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-264201 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 17:13 ET. Listed shows no prices and gives no investment advice.